Notably, thyroid cancers have the highest frequency of recurrent kinase fusions (63/498, 13%), and all fusion events including ALK, BRAF, MET, NTRK1, NTRK2, RAF1 and RET are mutually exclusive in this cancer type (Fig. 4). This evidence concerns the gene NTRK2 and thyroid gland carcinoma.